Dual VEGF/DLL4 Inhibition Overcome VEGF Therapy Resistance

Screenshot 2018-12-18 08.34.18.png

Potential Success of ABL001

Screenshot 2018-12-18 08.36.00.png

ABL001: Next Best-in-Class of Bispecific Antibody (BsAb)

Screenshot 2018-12-18 08.37.12.png